☆ 4.6 Letter

Assessment and reporting of quality-of-life measures in pivotal clinical trials of hematological malignancies

BLOOD ADVANCES (2021)

Get Full Text
Add to Collection

Journal

BLOOD ADVANCES
Volume 5, Issue 22, Pages 4630-4633

Publisher

ELSEVIER
DOI: 10.1182/bloodadvances.2021004190

Keywords

-

Categories

Hematology

Funding

  1. National Institutes of Health National Heart, Lung, and Blood Institute [5T32HL092332-18]
  2. National Institutes of Health National Cancer Institute [P50CA126752, P01CA094237]
  3. Stand Up To Cancer (SU2C)/American Association for Cancer Research (AACR) [604817]
  4. Meg Vosburg T-Cell Lymphoma Dream Team
  5. Leukemia and Lymphoma Society

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.